Show Menu

Hypertension Drugs Cheat Sheet by


> most common CVS disease
> elevated arterial BP damages vessels in renal, heart and brain
Renal failure, Coronary disease, Heart failure, Stroke, Diamentia


Systolic BP
Diastolic BP:
Stage 1 HTN:
Stage 2 HTN:
>= 160

Types of Hypert­ens­ion:

Essential Hypert­ension (85-90%):
Primary hypert­ension, no identi­fiable cause (genetic), can't be cured, can be controlled
Secondary Hypert­ension (10-15%):
Specific identified cause (comorbid disease or drug), can be cured when cause is eliminated

Seco­ndary Causes of HTN:

> Genetic factors
> Psycho­logical stress
> Enviro­nmental and Dietary Factors:
high salt diet, decreased calcium and phosphate intake, sedentary lifestyle
> Diseases:
renal, endocrine, vascular, renal diseases
> Drugs:
sympat­hom­imetic amines, amphet­amines, oral decong­estants (eg. pseudo­ehe­drine), cortic­ost­eroids, osteogens (C0Cs), NSAIDs, COX-2 inhibitors

Clinical presen­tat­ion:

- Often incidental finding
- Adults should get BP checks once a year
- Severe cases:
Headaches, visual distur­bances, target organ damage (stroke, ischemic heart disease, renal failure)

Normal regulation of BP:

Factors Influe­ncing BP:

Pote­ntial Mechanisms of Partho­gen­esis:

Increased Cardiac output:
Increased fluid volume from excessive sodium intake or renal sodium retention Venous constr­iction: due to excess stimul­ation of RAAS
Increased Peripheral resist­ance:
Excess stimul­ation of RAAS Sympat­hetic nervous system over-a­ctivity

Anti­hyp­ert­ensive Drugs:


Classes of Antihy­per­tensive Agents:

> Diuretics:
Reduce blood volume­=De­pletes the body of sodium, Venodi­lation
> Sympat­hop­legic agents:
Reduce peripheral vascular resist­ance, Inhibit cardiac function, Increase venous pooling capaci­tance vessels
> Direct vasodi­lators:
Reduce peripheral vascular resist­ance, Increase venous pooling capaci­tance vessels
> Angiot­ensin antago­nists:
Reduce peripheral vascular resist­ance, Reduce blood volume


- Reduce blood volume and cardiac output
- Cardiac output returns to normal
But peripheral vascular resistance declines
- Sodium
Contri­butes to vascular resistance = Increase vessel stiffness
- Venodi­lation
Altered sodium­-sodium calcium exchange

Vaso­dil­ation mechanism by Diuret­ics:

Thiazide Diuret­ics:

Use of Diuret­ics:

> Lower BP by 10-15 mmHg in most patients
> Thiazide diuretics –mild to moderate HTN
> Loop diuretics – severe HTN and hypert­ensive emerge­ncies
Adverse Effects (Thiazide Diuret­ics):
Potassium depletion – hypoka­lemia

Magnesium depletion

Hyperu­ric­emia- gouty attacks

Glucose intole­rance

Increase serum lipid concen­tra­tions

Sympat­hop­legic Drugs:

Centra­lly­-acting Drugs:
Methyl­dopa, clonidine
Adreno­ceptor antago­nists
Beta-b­loc­kers, alpha-1 blockers
Gangli­oni­c-b­locking Agents:
No longer used clinically ; hexame­thonium
Adrenergic neuron blocking agents:
Block the release of noradr­ena­line, Reserpine, guanet­hidine, debris­oquin, Not/rarely used clinically

Cent­ral­ly-­Acting Drugs:

- Methyl­dopa, clonidine
rarely used except clondine
- Reduces sympat­hetic outflow
- Compen­satory response mechanism:
salt retention
- Clonidine, guanabenz, guanfacine
Stimulate central alpha-2 adreno­ceptors
- Methyldopa – anologue of L-dopa
Results in the synthesis of a false neurot­ran­smitter
Alpha-­met­hyl­nor­adr­enaline = Stimulates central alpha-2 adreno­ceptors
Reduces cardiac output, PVR, relaxation of capaci­tance vessels
Rarely causes postural hypote­nsion
Adverse effects:
- Dry mouth
- Sedation
Contra­ind­ica­tion: Patients with depression
Caution: Abrupt discon­tin­uation can lead to hypert­ensive crisis

Adre­noc­eptor antago­nists: Beta-b­loc­kers

Non-se­lec­tive: Propra­nolol
Beta-1 selective: “BBEAM”
Betaxolol, bisopr­olol, esoprolol, atenolol, metoprolol, Cardio­sel­ective
Vasodi­lator beta-b­lockers
Also block alpha-1 recept­ors­,La­bet­olol, carvid­elol, nebivolol
Decrease cardiac output

Decrease peripheral vascular resistance

Inhibit stimul­ation of renin production by catech­ola­mines

Adverse effects= Heart block, bronch­oco­nst­ric­tion, diabetes, vivid dreams

Alpha-1 blocke­rs:

Prazosin, terazosin, doxazosin
Block alpha-1 receptors in arterioles and veins
Reduce peripheral resistance
Compen­satory mechanism:
salt and water retention
More effective when used with other drugs

Calcium Channel Blocke­rs:

> Dihydr­opy­ridines
amlodi­pine, isradi­pine, nicard­ipine, nimodi­pine, felodi­pine, nisold­ipine, lacidipine
> Non-di­hyd­rop­yri­dines
Verapamil, diltiazem, hydral­azine
Benzot­hia­zepine (dilti­azem)
Mechanism of action:
- Inhibit calcium influx through voltag­e-d­epe­ndent L-type calcium channels
- Relax arteriolar smooth muscle, reduce peripheral vascular resistance
- Cause coronary and peripheral vasodi­lation

CCB: Mechanisms of Action:

Dihydr­opy­ridine CCBs
Primary vasodi­lators (reduce PVR), All decrease cardiac contra­ctility except amlodipine and felodipine
Non-di­hyd­rop­yri­dines (dilti­azem, verapamil)
directly block the AV node, decrease heart rate,d­ecrease cardiac contra­ction
Adverse effects:
1. Flushing, peripheral oedema, tachyc­ardia, bradyc­ardia, heartblock
2. Headache, flushing, dizziness, palpit­ations, hypote­nsion
occur within a few hours of dosing, Associated w high initial doses or rapid increase in dose, Common with short-­acting prepar­ations
3. Ankle oedema: Due to a rise in intrac­api­llary pressure as a result of selective dilatation of precap­illary arteri­oles, NOT due to sodium retention, Relieved by bed rest
4. Gum Hypert­rophy: dihydr­opy­ridines
5. GIT: consti­pation (verap­amil), nausea, and vomiting

Inhi­bitors of Angiot­ens­in:

Angiot­ensin converting enzyme inhibitors (ACEIs)
Captopril, enalapril, Ramipril, fosino­pril, trandopril
Angiot­ensin receptor blockers (ARBs)
Losartan, valsartan, telmis­artan, irbesa­rtan, candes­artan

Inhi­bitors of Angiot­ens­in:

Adverse Effects
Dry cough
Can cause hyperk­alemia – potassium monitoring essential
Angioedema (substance P?)

ARBs =
No dry cough
Angiodema is less common than ACEIs

Contra­ind­icated in pregnancy

Comb­ination Treatment: Vasodi­lat­ors:


Mana­gement Approa­ch:

First-line agents: “ACD” drugs:
- A: ACEIs and ARBs
- C: Calcium channel antago­nists
- D: Diuretics (Thiaz­ides)

Second­-line agents:
- Beta-a­dre­noc­eptor blockers
- Aldost­erone antago­nists (spiro­nol­actone, eplere­none)
- Alpha-­blo­ckers (doxaz­osin, prazosin, terazosin)
- Loop diuretics (fruse­mide, torsemide)
- Direct vasodi­lators (hydra­lazine, minoxidil) [last-line of therapy]
- Central α-2 agonists (cloni­dine)
- Adrenergic antago­nists (reser­pine)


No comments yet. Add yours below!

Add a Comment

Your Comment

Please enter your name.

    Please enter your email address

      Please enter your Comment.

          Related Cheat Sheets

          Antiviral Therapy Cheat Sheet

          More Cheat Sheets by Carmilaa

          Introduction to Pharmacology Cheat Sheet
          Osteology of Maxilla and Mandible Cheat Sheet